Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients
Authors:
- R.P van HelvoirtRHR.P van Helvoirt
- J.W.R NortierJNJ.W.R Nortier
- I van der TweelITI van der Tweel
- H StruikmansHSH Struikmans
- 1 May 2003
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer
- Vol. 39 (8) , 1081-1088
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Early Start of Adjuvant Chemotherapy May Improve Treatment Outcome for Premenopausal Breast Cancer Patients With Tumors not Expressing Estrogen ReceptorsJournal of Clinical Oncology, 2000
- Can more breasts be saved if chemotherapy and radiotherapy are administered concomitantly?Annals of Oncology, 1999
- Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrenceCancer, 1995
- Factors influencing cosmetic results after conservation therapy for breast cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancerRadiotherapy and Oncology, 1994
- Effect of delay in radiation in the combined modality treatment of breast cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993
- Sequencing adjuvant chemotherapy and radiotherapy in breast cancer patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993
- Radiation therapy and breast conservation: Cosmetic results and complicationsSeminars in Radiation Oncology, 1992
- Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome.Journal of Clinical Oncology, 1991
- Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991